Skip Navigation



Carcinogenesis Advance Access published online on February 3, 2005

Carcinogenesis, doi:10.1093/carcin/bgi039
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
26/5/951    most recent
bgi039v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Crist, K. A.
Right arrow Articles by Lubet, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crist, K. A.
Right arrow Articles by Lubet, R. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Oxford University Press
Received July 15, 2004
Revised January 6, 2005
Accepted January 28, 2005

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Characterization of rat ovarian adenocarcinomas developed in response to direct instillation of 7,12-dimethylbenz[a]anthracene (DMBA) coated suture

Keith A. Crist 1*, Zhongqiu Zhang 2, Ming You 2, William T. Gunning 3, Phillip B. Conran 3, Vernon E. Steele 4, and Ronald A. Lubet 4

1 Department of Surgery, Medical College of Ohio, Toledo, Ohio
2 Department of Surgery and The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Mo
3 Department of Pathology, Medical College of Ohio, Toledo, Ohio
4 Chemoprevention Agent Development Group, National Cancer Institute, Rockville, Maryland

* To whom correspondence should be addressed.
Keith A. Crist, E-mail: kcrist{at}mco.edu


   Abstract

Human ovarian cancer is predominantly of epithelial cell origin (>90% of malignant tumors) and most often presents at advanced stage with poor prognosis. Most animal models of ovarian carcinoma yield thecal/granulosa cell tumors, rather than adenocarcinomas. Induction of adenocarcinoma in 10-45% of rats following ovarian implantation of DMBA coated silk suture has been reported. Here DMBA of 99% purity was melted at 124°C to impregnate a 1 cm length of sterile suture for direct ovarian implantation in Wistar Furth rats at 7 wk of age. DMBA treated ovaries showed nearly complete loss of primary follicles and degeneration of granulosa cells at 16 wk, consistent with known toxic response of the ovary to direct DMBA application. No tumors were present. Untreated right ovaries and sham dimethylsulfoxide treated ovaries were normal. Ovarian tumors in DMBA treated rats were first noted 26 wk post implantation reaching a cumulative tumor incidence of 77% (23/30) at 52 wk. Controls showed no evidence of tumor at 52 wks (0/31). Tumor histology was distributed as well differentiated adenocarcinoma (1/23), poorly differentiated adenocarcinoma (8/23), thecal/granulosa cell tumor (8/23), undifferentiated sarcoma (5/23) and 1 undifferentiated carcinoma with no adeno character. Tumors occasionally seeded to peritoneal mesentery, spleen and abdominal wall. Adenocarcinomas appeared to originate from the ovarian surface epithelium, with focal papillary extension into cystic space. Epithelial derived tumor cells positively react with antibodies to cytokeratin (8/8), epithelial cell adhesion molecule (Ep-CAM 5/5) and prostaglandin synthetase-1 (COX-1 4/4). Vimentin positive epithelial cells when present in adenocarcinomas (4/7), showed perinuclear staining, quite different from uniformly stained stromal cells in thecal/granulosa cell tumors (8/8). The thecal/granulosa cell tumors were Ep-CAM negative (0/5) and weakly COX-1 positive (4/4). Thus the DMBA suture model in rats yields epithelial derived tumors histologically similar to humans and should prove suitable for testing preventive or therapeutic agents.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
A. A. Hakim, C. P. Barry, H. J. Barnes, K. E. Anderson, J. Petitte, R. Whitaker, J. M. Lancaster, R. M. Wenham, D. K. Carver, J. Turbov, et al.
Ovarian Adenocarcinomas in the Laying Hen and Women Share Similar Alterations in p53, ras, and HER-2/neu
Cancer Prevention Research, February 1, 2009; 2(2): 114 - 121.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
A. Y. Ting, B. F. Kimler, C. J. Fabian, and B. K. Petroff
Tamoxifen Prevents Premalignant Changes of Breast, but not Ovarian, Cancer in Rats at High Risk for Both Diseases
Cancer Prevention Research, December 1, 2008; 1(7): 546 - 553.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
W. J. Murdoch, E. A. Van Kirk, and Youqing Shen
Pathogenic Reactions of the Ovarian Surface Epithelium to Ovulation, Dimethylbenzanthracene, and Estrogen are Negated by Vitamin E
Reproductive Sciences, October 1, 2008; 15(8): 839 - 845.
[Abstract] [PDF]


Home page
Mol Cancer ResHome page
Y. Wang, Z. Zhang, Y. Lu, R. Yao, D. Jia, W. Wen, M. LaRegina, K. Crist, R. Lubet, and M. You
Enhanced Susceptibility to Chemical Induction of Ovarian Tumors in Mice with a Germ Line p53 Mutation
Mol. Cancer Res., January 1, 2008; 6(1): 99 - 109.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. Y. Ting, B. F. Kimler, C. J. Fabian, and B. K. Petroff
Characterization of a preclinical model of simultaneous breast and ovarian cancer progression
Carcinogenesis, January 1, 2007; 28(1): 130 - 135.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.